Anti-ulcer activity of procyanidins preparation of water-soluble procyanidin-cimetidine complexes
As Healio previously reported, the FDA removed tirzepatide (Mounjaro/Zepbound, Eli Lilly) and semaglutide (Ozempic/Wegovy, Novo Nordisk) from its drug shortage list in 2024 and 2025, respectively, and now prohibits both 503A compounding pharmacies and 503B outsourcing facilities from distributing compounded versions of the drug
Understanding these factors can help optimize the benefits and minimize the risks of GLP-1 receptor agonists in managing type 2 diabetes
Alternative branded products Separately branded items may use a related active ingredient under their own formulation and pricing
Scientific References TRULICITY 1.5 mg solution for injection in pre-filled pen Summary of Product Characteristics
MMA (Methylmalonic Acidemia). Babys First Test, 21 June 2022 [Full Article] Moll S, Varga EA